자유게시판

14 Smart Ways To Spend Your Extra Personalized Depression Treatment Budget

작성자 정보

  • Vanessa 작성
  • 작성일

컨텐츠 정보

본문

Personalized Depression Treatment

Traditional treatment and medications don't work for a majority of people who are depressed. A customized treatment could be the answer.

Cue is a digital intervention platform that converts passively collected smartphone sensor data into personalized micro-interventions that improve mental health. We looked at the best-fitting personal ML models to each subject, using Shapley values to determine their features and predictors. The results revealed distinct characteristics that changed mood in a predictable manner over time.

Predictors of Mood

Depression is among the world's leading causes of mental illness.1 Yet, only half of those who have the condition receive treatment1. To improve outcomes, clinicians must be able identify and treat patients who are the most likely to respond to certain treatments.

The ability to tailor depression treatments is one way to do this. Researchers at the University of Illinois Chicago are developing new methods for predicting which patients will gain the most from specific treatments. They use sensors for mobile phones as well as a voice assistant that incorporates artificial intelligence, and other digital tools. With two grants totaling over $10 million, they will employ these tools to identify biological and behavioral predictors of response to antidepressant medications and psychotherapy.

The majority of research to so far has focused on sociodemographic and clinical characteristics. These include demographic variables like age, sex and educational level, clinical depression treatments characteristics like the severity of symptoms and comorbidities and biological indicators such as neuroimaging and genetic variation.

While many of these variables can be predicted from information available in medical records, few studies have used longitudinal data to explore the causes of mood among individuals. Few studies also take into account the fact that moods can vary significantly between individuals. Therefore, it is crucial to develop methods that allow for the determination of individual differences in mood predictors and the effects of treatment.

The team's new approach uses daily, in-person evaluations of mood and lifestyle variables using a smartphone app called AWARE, a cognitive treatment for depression evaluation with the BiAffect app and electroencephalography -- an imaging technique that monitors brain activity. The team is able to develop algorithms to detect patterns of behavior and emotions that are unique to each person.

coe-2023.pngThe team also created a machine learning algorithm to model dynamic predictors for each person's depression mood. The algorithm combines the individual differences to create a unique "digital genotype" for each participant.

This digital phenotype was found to be associated with CAT DI scores, a psychometrically validated severity scale for symptom severity. The correlation was not strong however (Pearson r = 0,08; P-value adjusted by BH 3.55 x 10 03) and varied significantly between individuals.

Predictors of symptoms

Depression is among the world's leading causes of disability1, but it is often underdiagnosed and undertreated2. Depression disorders are usually not treated because of the stigma attached to them and the absence of effective interventions.

To aid in the development of a personalized treatment, it is essential to identify predictors of symptoms. The current methods for predicting symptoms rely heavily on clinical interviews, which are unreliable and only detect a few features associated with depression.

Using machine learning to combine continuous digital behavioral phenotypes that are captured by sensors on smartphones and a validated online mental health tracker (the Computerized Adaptive Testing Depression Inventory, the CAT-DI) with other predictors of severity of symptoms has the potential to increase the accuracy of diagnostics and the effectiveness of treatment for depression. These digital phenotypes allow continuous, high-resolution measurements as well as capture a wide range of distinctive behaviors and activity patterns that are difficult to capture using interviews.

The study included University of California Los Angeles students who had mild to severe depression symptoms who were participating in the Screening and Treatment for Anxiety and Depression program29, which was developed as part of the UCLA Depression Grand Challenge. Participants were directed to online assistance or in-person clinics according to the severity of their depression. Patients who scored high on the CAT-DI scale of 35 65 were given online support by an instructor and those with a score 75 patients were referred to psychotherapy in person.

Participants were asked a series of questions at the beginning of the study about their demographics and psychosocial traits. The questions asked included age, sex and education as well as financial status, marital status as well as whether they divorced or not, current suicidal thoughts, intentions or attempts, and the frequency with which they consumed alcohol. The CAT-DI was used to rate the severity of depression symptoms on a scale ranging from zero to 100. The CAT-DI assessment was carried out every two weeks for those who received online support, and weekly for those who received in-person assistance.

Predictors of Treatment Response

Research is focusing on personalized depression treatment. Many studies are focused on finding predictors, which can help doctors determine the most effective drugs to treat each individual. Pharmacogenetics, in particular, uncovers genetic variations that affect how the human body metabolizes drugs. This allows doctors to select drugs that are likely to be most effective for each patient, minimizing the time and effort involved in trials and errors, while eliminating any side effects that could otherwise slow progress.

Another option is to build prediction models that combine the clinical data with neural imaging data. These models can then be used to identify the most appropriate combination of variables that is predictors of a specific outcome, such as whether or not a drug will improve symptoms and mood. These models can also be used to predict the response of a patient to an existing treatment which allows doctors to maximize the effectiveness of the current treatment.

A new generation of machines employs machine learning techniques like supervised and classification algorithms such as regularized logistic regression, and tree-based methods to combine the effects from multiple variables and improve predictive accuracy. These models have proven to be useful in the prediction of treatment outcomes like the response to antidepressants. These methods are becoming more popular in psychiatry and will likely become the standard of future medical practice.

In addition to the ML-based prediction models The study of the underlying mechanisms of depression continues. Recent findings suggest that depression is connected to the malfunctions of certain neural networks. This suggests that an the treatment For Panic attacks and depression for extreme depression treatment will be individualized based on targeted therapies meds that treat anxiety and depression target these neural circuits to restore normal functioning.

Internet-based interventions are an option to accomplish this. They can offer more customized and personalized experience for patients. One study found that a program on the internet was more effective than standard treatment in reducing symptoms and ensuring the best quality of life for those with MDD. A randomized controlled study of a customized treatment for depression revealed that a significant number of patients experienced sustained improvement and fewer side consequences.

Predictors of Side Effects

A major issue in personalizing depression treatment is predicting the antidepressant medications that will have the least amount of side effects or none at all. Many patients experience a trial-and-error approach, with several medications prescribed before finding one that is safe and effective. Pharmacogenetics offers a new and exciting method of selecting antidepressant medicines that are more effective and precise.

Several predictors may be used to determine which antidepressant is best to prescribe, including gene variants, phenotypes of patients (e.g., sex or ethnicity) and comorbidities. To identify the most reliable and reliable predictors of a specific treatment, random controlled trials with larger sample sizes will be required. This is because it could be more difficult to determine the effects of moderators or interactions in trials that comprise only one episode per person instead of multiple episodes spread over a period of time.

Furthermore, the prediction of a patient's response to a particular medication will likely also need to incorporate information regarding symptoms and comorbidities and the patient's previous experience with tolerability and efficacy. There are currently only a few easily measurable sociodemographic variables as well as clinical variables appear to be consistently associated with response to MDD. These include gender, age, race/ethnicity, SES, BMI and the presence of alexithymia.

There are many challenges to overcome when it comes to the use of pharmacogenetics for depression treatment. First it is necessary to have a clear understanding of the underlying genetic mechanisms is needed as well as an understanding of what is a reliable predictor of treatment response. Additionally, ethical issues like privacy and the responsible use of personal genetic information, must be carefully considered. Pharmacogenetics could be able to, over the long term help reduce stigma around mental health treatment and improve the outcomes of treatment. However, as with all approaches to psychiatry, careful consideration and planning is necessary. The best method is to provide patients with a variety of effective depression medication options and encourage them to speak freely with their doctors about their concerns and experiences.

관련자료

댓글 0
등록된 댓글이 없습니다.
알림 0